NEW MEDICINES LISTED ON THE PBS

Australians suffering from melanoma and multiple sclerosis have new treatment options, with new and amended PBS listings. 🔸 Tafinlar® (dabrafenib) and Mekinist® (trametinib) will be extended to include subsidy for post-surgery treatment for patients who have Stages IIIB, IIIC and IIID melanoma. 🔸 Gilenya® (fingolimod) will be amended to include a new strength of this medicine for…

Details

Supporting our Veterans

Thousands of offers are now available to Veteran Card holders from businesses across Australia. This is part of the Australian Defence Veterans’ Covenant which passed Parliament recently.   Federal Member for Page Kevin Hogan said the Veteran Card is providing the opportunity for businesses and organisations to show their support of veterans.   “So far…

Details

Breast cancer MRI added to Medicare

Women with or suspected of having breast cancer will be able to claim Medicare benefits for magnetic resonance imaging (MRI) scans, from 1 November 2019.   Federal Member for Page, Kevin Hogan said approximately 14,000 patients each year, predominantly women, will benefit from these services.   Medicare rebates will be available for MRI scans for:…

Details

Life-changing medicines listings to save cystic fibrosis patients up to $250,000 a year

The Federal Government will provide immediate access to life-changing medicines on the Pharmaceutical Benefits Scheme (PBS) to help support people with cystic fibrosis, saving them and their families up to $250,000 per year. From 1 December 2019, the life-changing cystic fibrosis medicine Symdeko® will be listed on the PBS for patients with cystic fibrosis over…

Details

Disaster payments available for those worst affected by bushfires

The Federal Government is providing a one-off disaster payments to those worst affected by the devastating bushfires that have swept through Northern New South Wales and Southern Queensland. Federal Member for Page, Kevin Hogan said the Government has activated Australian Government Disaster Recovery Payment (AGDRP) which provides a non-means tested payment of $1000 for eligible…

Details